Claudia Pasqualini Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Survival and prognostic factors for children 12 to 18 months of age with stage 4 non-MYCN amplified neuroblastoma treated in the SIOPEN high-risk trial — Poster Session 1 with wine & cheese